This difference was maintained only in the group of normal weight when T2DM patients were excluded from the analysis (Supplementary Figure S2B), demonstrating that obesity could play a role in the regulation of P2X7 expression after chemotherapy. Here, P2RX7 is linked to obesity due to melanocortin 4 receptor deficiency.